NeuroFlow, a behavioral well being firm, secured a $25 million progress funding led by progress fairness affect investor SEMCAP Well being, bringing its complete funding to $32 million.
WHAT THEY DO
NeuroFlow’s cloud-based platform permits healthcare suppliers to trace, assess and join with sufferers between conventional workplace visits. The corporate additionally presents AI-driven scientific choice assist with suggestions for the following steps for particular person sufferers.
The Pennsylvania-based firm will use the funds to develop its community and enhance R&D investments to develop its platform. It would additionally enhance its workforce in all departments.
“We’re excited to usher in a powerful accomplice like SEMCAP to assist our subsequent stage of progress. This offers us the chance to satisfy the demand we’re experiencing and to put money into a platform that helps ship a happier, more healthy high quality of life for these throughout the spectrum of psychological well being wants. With this financing, we’ll deal with strategic hiring, R&D for the platform and the launch of a Spanish-language app,” James Kanka, NeuroFlow’s vice chairman of promoting, instructed MobiHealthNews in an electronic mail.
Final month, NeuroFlow introduced a collaboration with CirrusMD, a startup providing on-demand, text-based telehealth, the place CirrusMS would leverage NeuroFlow’s scientific choice assist platform, affected person engagement instruments and intervention companies.
In February, NeuroFlow introduced a partnership with Aflac, giving the insurance coverage supplier’s staff entry to digital psychological well being sources through NeuroFlow’s instructional content material service.